305 related articles for article (PubMed ID: 6783607)
1. Penicillin-binding proteins of Pseudomonas aeruginosa. Comparison of two strains differing in their resistance to beta-lactam antibiotics.
Curtis NA; Orr D; Boulton MG; Ross GW
J Antimicrob Chemother; 1981 Feb; 7(2):127-36. PubMed ID: 6783607
[No Abstract] [Full Text] [Related]
2. [Mechanism of susceptibility and resistance of bacteria to beta-lactam antibiotics].
Tsuji A
Nihon Rinsho; 1991 Oct; 49(10):2254-60. PubMed ID: 1749080
[No Abstract] [Full Text] [Related]
3. [Actions of beta-lactam antibiotics against Pseudomonas aeruginosa: their effects on penicillin-binding proteins and on bactericidal activity of macrophages].
Nakamuta S
Nihon Hinyokika Gakkai Zasshi; 1983 Dec; 74(12):2031-42. PubMed ID: 6429401
[No Abstract] [Full Text] [Related]
4. Role of permeability barriers in resistance to beta-lactam antibiotics.
Nikaido H
Pharmacol Ther; 1985; 27(2):197-231. PubMed ID: 2412244
[No Abstract] [Full Text] [Related]
5. Sch 29482: activity against susceptible and beta-lactam resistant variants of Enterobacteriaceae.
Chabbert YA; Jaffé A
J Antimicrob Chemother; 1982 Feb; 9 Suppl C():203-12. PubMed ID: 6977531
[No Abstract] [Full Text] [Related]
6. Contribution of the MexAB-OprM multidrug efflux system to the beta-lactam resistance of penicillin-binding protein and beta-lactamase-derepressed mutants of Pseudomonas aeruginosa.
Srikumar R; Tsang E; Poole K
J Antimicrob Chemother; 1999 Oct; 44(4):537-40. PubMed ID: 10588316
[TBL] [Abstract][Full Text] [Related]
7. beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment.
Godfrey AJ; Bryan LE; Rabin HR
Antimicrob Agents Chemother; 1981 May; 19(5):705-11. PubMed ID: 6457554
[TBL] [Abstract][Full Text] [Related]
8. Penicillin-binding proteins and the future of beta-lactam antibiotics. The Seventh Fleming Lecture.
Spratt BG
J Gen Microbiol; 1983 May; 129(5):1247-60. PubMed ID: 6352855
[No Abstract] [Full Text] [Related]
9. Isolation of two types of Pseudomonas aeruginosa mutants highly sensitive to a specific group of beta-lactam antibiotics and with defect in penicillin-binding proteins.
Noguchi H; Fukasawa M; Komatsu T; Iyobe S; Mitsuhashi S
J Antibiot (Tokyo); 1980 Dec; 33(12):1521-6. PubMed ID: 6788742
[TBL] [Abstract][Full Text] [Related]
10. [Penicillin--binding protein: the target for beta-lactam antibiotics, beta-lactamases and their inhibitors].
Lessel J
Pharm Unserer Zeit; 1996 Jan; 25(1):17-27. PubMed ID: 8882750
[No Abstract] [Full Text] [Related]
11. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
Leying HJ; Büscher KH; Cullmann W; Then RL
Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
[TBL] [Abstract][Full Text] [Related]
12. Structural and mechanistic aspects of evolution of beta-lactamases and penicillin-binding proteins.
Massova I; Mobashery S
Curr Pharm Des; 1999 Nov; 5(11):929-37. PubMed ID: 10539997
[TBL] [Abstract][Full Text] [Related]
13. [Penicillin-binding proteins. Their enzymatic activity and properties].
Griaznova NS; Subbotina NA
Antibiot Med Biotekhnol; 1986 Jul; 31(7):487-98. PubMed ID: 3532933
[No Abstract] [Full Text] [Related]
14. Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms.
Pagani L; Debiaggi M; Tenni R; Cereda PM; Landini P; Romero E
Microbiologica; 1988 Jan; 11(1):47-53. PubMed ID: 2832709
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the novel penem CGP 31 608 and its enantiomer with type Id beta-lactamase and penicillin-binding proteins.
Mett H; Schacher B; Schneider P; Zak O
Eur J Clin Microbiol; 1987 Dec; 6(6):674-8. PubMed ID: 3126060
[TBL] [Abstract][Full Text] [Related]
16. Resistance of Clostridium perfringens to beta-lactam antibiotics mediated by a decreased affinity of a single essential penicillin-binding protein.
Williamson R
J Gen Microbiol; 1983 Aug; 129(8):2339-42. PubMed ID: 6313857
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of resistance of enterococci to beta-lactam antibiotics.
Fontana R; Canepari P; Lleò MM; Satta G
Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):103-5. PubMed ID: 2180705
[TBL] [Abstract][Full Text] [Related]
18. [Carbapenem antibiotics].
Watanabe A
Nihon Rinsho; 2003 Feb; 61 Suppl 2():737-43. PubMed ID: 12722309
[No Abstract] [Full Text] [Related]
19. Beta-lactam-fosfomycin antagonism involving modification of penicillin-binding protein 3 in Pseudomonas aeruginosa.
Reguera JA; Baquero F; Berenguer J; Martinez-Ferrer M; Martinez JL
Antimicrob Agents Chemother; 1990 Nov; 34(11):2093-6. PubMed ID: 2127343
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of beta-lactam resistance in Haemophilus influenzae.
Gutmann L; Williamson R; Collatz E; Acar JF
Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):610-5. PubMed ID: 3143572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
